Microbial ecosystems biology in the human gut
This project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions.
Projectdetails
Introduction
The gut microbiota has wide-ranging effects on host health and represents a promising target for therapeutic manipulation, particularly in early life. Imbalances in the gut microbiota precede the development of conditions such as overweight and immunological diseases, which exert a significant burden on society and on individuals.
Importance of Early Intervention
Early identification and treatment of gut microbiota imbalance in childhood thus offers great potential in combating these problems, and will become an important part of health care in the future. However, achieving this goal will require a high-level understanding of the processes that regulate the microbial populations.
Current Knowledge Gaps
Currently, our knowledge of the principles governing gut microbiota responses to treatments is insufficient for reliable and targeted microbiota modification. I hypothesize that conceptual limitations are a significant reason for the current inability to reliably predict microbiota responses to treatments and to modify the microbiota.
Project Overview
In this interdisciplinary project, based on daily multiomic time series of child gut microbiota and diet and health diaries, I integrate the theoretical and analytical framework of:
- Population ecology
- Novel next-generation metagenomics-based high-resolution quantitative microbiota profiling
- Genome-scale metabolic reconstructions
into an ecosystem model of the child gut microbiota.
Expected Outcomes
The result will be an unprecedented level of understanding of how the gut microbes interact and respond to external forces. The concept can be applied widely to study the numeric and functional microbiota responses to any treatment and to design targeted interventions based on the predicted responses.
Conclusion
The project represents the important next step in microbiota research from description to mechanistic understanding.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.485.413 |
Totale projectbegroting | € 1.485.413 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 31-12-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- HELSINGIN YLIOPISTOpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modellingThis project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions. | ERC Starting... | € 1.499.323 | 2024 | Details |
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome SpeciesThis project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health. | ERC Starting... | € 1.499.980 | 2023 | Details |
Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactionsThis project aims to systematically study metabolic interactions between gut microbiota and hosts using drug biotransformation to improve understanding of microbiome-related health variations and drug responses. | ERC Starting... | € 1.894.858 | 2023 | Details |
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutritionThe InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Microbiome-based diagnostics and therapeuticsThis project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression. | ERC Proof of... | € 150.000 | 2023 | Details |
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling
This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species
This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.
Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactions
This project aims to systematically study metabolic interactions between gut microbiota and hosts using drug biotransformation to improve understanding of microbiome-related health variations and drug responses.
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.
Microbiome-based diagnostics and therapeutics
This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MicroBioDx: karakterisatie van microbioom-gastheer interactiesTenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren. | Mkb-innovati... | € 143.080 | 2021 | Details |
MicroBioDx: karakterisatie van microbioom-gastheer interacties
TenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren.